ACELYRIN, Inc.
SLRNDelisted May 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962918
ACELYRIN, Inc. was delisted on May 21, 2025; its insiders filed their last Form 4 on May 23, 2025; 106 institutions reported holding it in 13F filings for Q1 2025, worth $182.6M in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding ACELYRIN, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 122 | 1 | 126 | +5 |
| Shares | 87.2M | 35.1K | 88.0M | +766.9K (+0.9%) |
| Value | $430.2M | $173.0K | $276.4M | −$153.6M (−35.7%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held ACELYRIN, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,515,878 | $4.76M | 0.02% |
| Susquehanna Fundamental Investments, LLC | 237,465 | $745.6K | 0.01% |
| Exome Asset Management LLC | 234,435 | $736.1K | 0.55% |
| Wellington Management Group LLP | 180,539 | $566.9K | 0.00% |
| ExodusPoint Capital Management, LP | 134,680 | $423.0K | 0.00% |
| Stonepine Capital Management, LLC | 132,870 | $417.2K | 0.34% |
| Dimensional Fund Advisors LP | 118,241 | $371.3K | 0.00% |
| BNP Paribas Arbitrage, SA | 75,114 | $235.9K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 14,886 | $46.7K | 0.00% |
| Rpo LLC | 14,693 | $46.1K | 0.06% |
| HSBC Holdings PLC | 11,663 | $36.3K | 0.00% |
| 4WEALTH Advisors, Inc. | 11,212 | $35.2K | 0.04% |
| XTX Topco Ltd | 10,369 | $32.6K | 0.00% |
| GF Fund Management Co. Ltd. | 2,107 | $6.62K | 0.00% |
| Comerica Bank | 1,428 | $4.48K | 0.00% |
| Signaturefd, LLC | 175 | $550 | 0.00% |
| Skopos Labs, Inc. | 62 | $195 | 0.00% |
| Allworth Financial LP | 65 | $132 | 0.00% |
| IFP Advisors, Inc | 0 | $6 | 0.00% |
Sold out (14)
Institutions that held ACELYRIN, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Acuta Capital Partners, LLC | 364,000 | $1.79M |
| Woodline Partners LP | 357,094 | $1.76M |
| Point72 Asset Management, L.P. | 250,300 | $1.23M |
| Artia Global Partners LP | 93,114 | $459.1K |
| Squarepoint Ops LLC | 83,345 | $410.9K |
| Shay Capital LLC | 78,500 | $387.0K |
| Polar Asset Management Partners Inc. | 71,700 | $353.5K |
| Balyasny Asset Management LLC | 43,868 | $216.3K |
| Cubist Systematic Strategies, LLC | 19,252 | $94.9K |
| US Bancorp | 16,854 | $83.1K |
| Virtu Financial LLC | 10,080 | $50.0K |
| SRS Capital Advisors, Inc. | 185 | $913 |
| Clearstead Advisors, LLC | 114 | $563 |
| Capital Performance Advisors LLP | 102 | $503 |
Not filed for Q4 2024 yet (1)
Institutions that held ACELYRIN, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| AJOVista, LLC | 35,084 | $173.0K |